DTGCX
Price
$38.39
Change
+$0.26 (+0.68%)
Updated
Jun 12 closing price
Net Assets
567.66M
SLMCX
Price
$235.61
Change
+$2.76 (+1.19%)
Updated
Jun 12 closing price
Net Assets
28.23B
Interact to see
Advertisement

DTGCX vs SLMCX

Header iconDTGCX vs SLMCX Comparison
Open Charts DTGCX vs SLMCXBanner chart's image
DTGCX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
DTGCX vs. SLMCX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTGCX is a Hold and SLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 28.2B vs. DTGCX (568M). DTGCX (0.00) and SLMCX (0.00) have matching dividends . DTGCX was incepted earlier than SLMCX: DTGCX (27 years) vs SLMCX (43 years). DTGCX (1.97) is less costly to investors than SLMCX (1.16). DTGCX (33.84) and SLMCX (33.00) have comparable annual turnover. DTGCX has a lower initial minimum investment than SLMCX: DTGCX (1000) vs SLMCX (2000). SLMCX annual gain was more profitable for investors over the last year : 89.55 vs. DTGCX (17.65). SLMCX return over 5 years is better than : 88.38 vs. DTGCX (-6.93).
DTGCXSLMCXDTGCX / SLMCX
Total Expense Ratio1.971.16170%
Annual Report Gross Expense Ratio1.971.16170%
Fund Existence27 years43 years-
Gain YTD27.88150.35755%
Front LoadN/A6%-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets568M28.2B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.6589.5520%
Returns for 3 years65.90124.3953%
Returns for 5 years-6.9388.38-8%
Returns for 10 years16.76325.525%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEN6.79N/A
N/A
Wendy's Company
OACC10.66N/A
N/A
Oaktree Acquisition Corp. III Life Sciences
BLIV2.39N/A
N/A
BeLive Holdings
VRTX444.92-0.12
-0.03%
Vertex Pharmaceuticals
MIRM99.35-0.20
-0.20%
Mirum Pharmaceuticals